Immune Netw.  2018 Oct;18(5):e39. 10.4110/in.2018.18.e39.

Decreased Expression of Sphingosine-1-Phosphate Receptor 1 in the Blood Leukocyte of Rheumatoid Arthritis Patients

• Choi HS
• Kim KH
• Jin S
• Kim J
• Yoo I
• Pack SP
• Ha UH
• Park TW
• Choi SA
• Yuk SH
• Kang SW
• Jung YW

• KMID: 2424205
• DOI: http://doi.org/10.4110/in.2018.18.e39

Abstract

Sphingosine-1-phosphate (S1P) plays an important role in trafficking leukocytes and developing immune disorders including autoimmunity. In the synovium of rheumatoid arthritis (RA) patients, increased expression of S1P was reported, and the interaction between S1P and S1P receptor 1 (S1P1) has been suggested to regulate the expression of inflammatory genes and the proliferation of synovial cells. In this study, we investigated the level of S1P1 mRNA expression in the blood leukocytes of RA patients. In contrast to the previous reports, the expression level of this gene was not correlated to their clinical scores, disease durations and ages. However, S1P1 was transcribed at a significantly lower level in the circulating leukocytes of RA patients when compared to age-, and sex-matched healthy controls. Since these data may suggest the participation of S1P1, further studies are needed to determine the role of this receptor in the pathogenesis of RA.

Keyword

Sphingosine-1-phosphate; Rheumatoid arthritis; S1P receptor; Leukocytes

MeSH Terms

Arthritis, Rheumatoid*
Autoimmunity
Humans
Immune System Diseases
Leukocytes*
Receptors, Lysosphingolipid*
RNA, Messenger
Synovial Membrane
RNA, Messenger
Receptors, Lysosphingolipid